Assessment of lncRNA GAS5, lncRNA HEIH, lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers: Recent insights into Egyptian patients with hepatitis C virus type 4

Table 5 Factors that predict relapsed hepatitis C virus patients (n = 30) from SOF + SIM therapy (n = 30) using logistic regression analysis

Parameter	B	SE	P value	Odds ratio	Odds ratio (95%CI)
Univariate analysis
LncRNA-Gas5	2.35	0.564	< 0.001b	10.48	3.47-31.67
LncRNA-BISPR	2.27	0.555	< 0.001b	9.69	3.26-28.73
LncRNA-HEIH	1.99	0.599	0.001b	7.31	2.26-23.63
mRNA BST2	-3.15	0.858	< 0.001b	0.042	0.08-0.228
ALT (IU/L)	0.87	0.037	0.01a	1.09	1.01-1.17
ALP (IU/L)	0.069	0.022	0.002b	1.07	1.02-1.11
Multivariate analysis
LncRNA-Gas5	1.46	0.69	0.03a	4.322	1.12-16.70
LncRNA-HEIH	1.4	0.714	0.04a	8.885	1.00-16.51

^aP < 0.05,

^bP < 0.01, indicates statistical significance. ALT: Alanine aminotransferases; ALP: Alkaline phosphatase.